Abstract
The use of the CyberKnife® (Accuray Incorporated, Sunnyvale, CA) for radiosurgical treatment of lung tumors [1] typically requires placement of one or more gold fiducials for tracking during treatment. Possible exceptions to this requirement are tumors involving the posterior chest wall, which may be localized with Xsightℳ (Accuray Incorporated, Sunnyvale, CA) based on spinal anatomy. Placement of gold fiducial seeds has been associated with post-placement pneumothorax at rates of 25–40% [1]. Some of these patients will require treatment by chest tube placement, and all of them will require repeated physician exams and radiological follow-up. In addition, some patients are refused consideration for radiosurgery for fear they will be unable to tolerate a potential pneumothorax. Pneumothorax prevention, therefore, has become a major priority in CyberKnife radiosurgery for lung cancer.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Whyte RI, Crownover R, Murphy MJ, et al. Stereotactic radiosurgery for lung tumors: preliminary report of a phase I trial. Ann Thorac Surg 2003;75:1097–1101.
Reichner CA, Collins BT, Gagnon GJ, et al. The placement of gold fiducials for CyberKnife stereotactic radiosurgery using a modified transbronchial needle aspiration technique. Journal of Bronchology 2005;12:193–195.
McGarry RC, Papiez L, Williams M, et al. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys 2005;63:1010–1015.
Nagata Y, Takayama K, Matsuo Y, et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005;63:1427–1431.
Onishi H, Araki T, Shirato H, et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 2004;101:1623–1631.
Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006; 24:4833–4839.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Blalock, J.W., Medbery, C.A., Morrison, A.E., Young, M.M., Hensley, J., Harriet, V. (2007). Use of a Blood Patch Technique to Prevent Pneumothorax During Insertion of Lung Fiducials. In: Urschel, H.C., Kresl, J.J., Luketich, J.D., Papiez, L., Timmerman, R.D., Schulz, R.A. (eds) Treating Tumors that Move with Respiration. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69886-9_10
Download citation
DOI: https://doi.org/10.1007/978-3-540-69886-9_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-69885-2
Online ISBN: 978-3-540-69886-9
eBook Packages: MedicineMedicine (R0)